Suher Zada

920 total citations
39 papers, 700 citations indexed

About

Suher Zada is a scholar working on Molecular Biology, Cancer Research and Hepatology. According to data from OpenAlex, Suher Zada has authored 39 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Cancer Research and 7 papers in Hepatology. Recurrent topics in Suher Zada's work include MicroRNA in disease regulation (9 papers), Parasites and Host Interactions (6 papers) and Hepatitis C virus research (5 papers). Suher Zada is often cited by papers focused on MicroRNA in disease regulation (9 papers), Parasites and Host Interactions (6 papers) and Hepatitis C virus research (5 papers). Suher Zada collaborates with scholars based in Egypt, United Kingdom and France. Suher Zada's co-authors include Eman El‐Ahwany, Rashika El Ridi, Mahmoud ElHefnawi, Mona Zoheiry, Gordon C. Tucker, M. Delarue, Jean Paul Thiery, Jean‐Claude Boucaut, Abdel Hakim Saad and Nageh K. Allam and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Langmuir.

In The Last Decade

Suher Zada

39 papers receiving 685 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suher Zada Egypt 16 332 146 101 82 62 39 700
Michael J. Johnston United Kingdom 17 520 1.6× 116 0.8× 56 0.6× 258 3.1× 17 0.3× 28 1.2k
Monica Linder Germany 16 675 2.0× 39 0.3× 129 1.3× 255 3.1× 59 1.0× 28 1.3k
Aline Fiebig‐Comyn Canada 16 1.1k 3.3× 72 0.5× 66 0.7× 108 1.3× 11 0.2× 26 1.7k
Christian Frech Germany 21 782 2.4× 164 1.1× 47 0.5× 97 1.2× 16 0.3× 57 1.5k
Dwight Barnes United States 15 445 1.3× 84 0.6× 54 0.5× 156 1.9× 13 0.2× 22 907
Supriyo Chakraborty India 21 1.3k 3.9× 379 2.6× 138 1.4× 120 1.5× 11 0.2× 74 1.6k
Deborah Maguire Australia 9 390 1.2× 67 0.5× 110 1.1× 352 4.3× 12 0.2× 11 853
Omar Quraishi Canada 12 290 0.9× 155 1.1× 37 0.4× 53 0.6× 8 0.1× 13 645
Xinlei Li China 21 500 1.5× 115 0.8× 184 1.8× 81 1.0× 215 3.5× 62 1.1k
Trinidad Hernández‐Caselles Spain 19 346 1.0× 44 0.3× 99 1.0× 525 6.4× 51 0.8× 34 1.1k

Countries citing papers authored by Suher Zada

Since Specialization
Citations

This map shows the geographic impact of Suher Zada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suher Zada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suher Zada more than expected).

Fields of papers citing papers by Suher Zada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suher Zada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suher Zada. The network helps show where Suher Zada may publish in the future.

Co-authorship network of co-authors of Suher Zada

This figure shows the co-authorship network connecting the top 25 collaborators of Suher Zada. A scholar is included among the top collaborators of Suher Zada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suher Zada. Suher Zada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ella, Dalal A. Abou El, et al.. (2022). The natural isoflavone Biochanin‐A synergizes 5‐fluorouracil anticancer activity in vitro and in vivo in Ehrlich solid‐phase carcinoma model. Phytotherapy Research. 36(3). 1310–1325. 23 indexed citations
2.
Abdellatif, Ahmed, et al.. (2019). Circulating MicroRNAs in Duchenne Muscular Dystrophy. Clinical Neurology and Neurosurgery. 189. 105634–105634. 9 indexed citations
3.
Zada, Suher, et al.. (2019). Mineralization of electrospun gelatin/CaCO3 composites: A new approach for dental applications. Materials Science and Engineering C. 100. 655–664. 20 indexed citations
4.
El‐Ahwany, Eman, et al.. (2019). MicroRNA-122a as a non-invasive biomarker for HCV genotype 4-related hepatocellular carcinoma in Egyptian patients. Archives of Medical Science. 15(6). 1454–1461. 33 indexed citations
5.
El‐Ahwany, Eman, et al.. (2018). miRNA-221 and miRNA-222 are promising biomarkers for progression of liver fibrosis in HCV Egyptian patients. Virus Research. 253. 135–139. 35 indexed citations
6.
El‐Ahwany, Eman, et al.. (2016). Circulating miRNAs as Predictor Markers for Activation of Hepatic Stellate Cells and Progression of HCV-Induced Liver Fibrosis. SHILAP Revista de lepidopterología. 8(1). 1804–1810. 22 indexed citations
7.
El‐Ahwany, Eman, et al.. (2016). The Role of MicroRNAs in Response to Interferon Treatment of Chronic Hepatitis C patient. SHILAP Revista de lepidopterología. 8(2). 1994–2000. 1 indexed citations
8.
ElHefnawi, Mahmoud, Tae Kyu Kim, Eman El‐Ahwany, et al.. (2016). In Silico Design and Experimental Validation of siRNAs Targeting Conserved Regions of Multiple Hepatitis C Virus Genotypes. PLoS ONE. 11(7). e0159211–e0159211. 24 indexed citations
9.
Tolba, Mai F., Andrew W. Liu, Eman El‐Ahwany, et al.. (2016). Novel combination of sorafenib and biochanin-A synergistically enhances the anti-proliferative and pro-apoptotic effects on hepatocellular carcinoma cells. Scientific Reports. 6(1). 30717–30717. 37 indexed citations
10.
Eldehna, Wagdy M., Mohamed Farès, Hany S. Ibrahim, et al.. (2015). Indoline ureas as potential anti-hepatocellular carcinoma agents targeting VEGFR-2: Synthesis, in vitro biological evaluation and molecular docking. European Journal of Medicinal Chemistry. 100. 89–97. 59 indexed citations
11.
Amer, Marwa, et al.. (2013). 283 PREDICTION OF miRNA TARGET GENES INVOLVED IN LIVER CANCER PATHWAYS AND ITS VALIDATION. Journal of Hepatology. 58. S120–S120. 1 indexed citations
12.
El‐Ahwany, Eman, et al.. (2012). Protective Role of Purified Cysteine Proteinases against Fasciola gigantica Infection in Experimental Animals. Korean Journal of Parasitology. 50(1). 45–51. 9 indexed citations
13.
Zoheiry, Mona, et al.. (2010). Differential expression of cell cycle regulators in HCVinfection and related hepatocellular carcinoma. World Journal of Hepatology. 2(1). 32–32. 15 indexed citations
14.
Aboushousha, Tarek, et al.. (2009). Hepatic mRNA expression of histone (H3): an early predictor of tumorgenic changes in chronic hepatitis C. Archives of Medical Science. 5(4). 506–512. 2 indexed citations
15.
Youssif, Aliaa A. A., et al.. (2009). Natural Genetic Engineering of Hepatitis C Virus NS5A for Immune System Counterattack. Annals of the New York Academy of Sciences. 1178(1). 173–185. 7 indexed citations
16.
El‐Ahwany, Eman, et al.. (2000). Immunolocalization of macrophage adhesion molecule-1 and macrophage inflammatory protein-1 in schistosomal soluble egg antigen-induced granulomatous hyporesponsiveness. International Journal for Parasitology. 30(7). 837–842. 9 indexed citations
17.
18.
Ridi, Rashika El, Moustafa Mansour, & Suher Zada. (1991). Immunoglobulins of the Snake Psammophis sibilans. Studies Using a Monoclonal Antibody. Immunobiology. 184(1). 1–13. 9 indexed citations
19.
Ridi, Rashika El, et al.. (1988). Cyclic changes in the differentiation of lymphoid cells in reptiles. Cell Differentiation. 24(1). 1–8. 34 indexed citations
20.
Zada, Suher, et al.. (1985). Ontogeny of hemopoietic and lymphopoietic tissues in the lizard Chalcides ocellatus (Reptilia, Sauna, Scincidae). Journal of Morphology. 185(2). 241–253. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael J. Johnston Breakdown of academic impact, for papers by Monica Linder Breakdown of academic impact, for papers by Aline Fiebig‐Comyn Breakdown of academic impact, for papers by Christian Frech Breakdown of academic impact, for papers by Dwight Barnes Breakdown of academic impact, for papers by Supriyo Chakraborty Breakdown of academic impact, for papers by Deborah Maguire Breakdown of academic impact, for papers by Omar Quraishi Breakdown of academic impact, for papers by Xinlei Li Breakdown of academic impact, for papers by Trinidad Hernández‐Caselles
Rankless by CCL
2026